Egg prices are on watch after Cal-Maine discloses avian flu at a Florida facility

Cal-Maine Foods (CALM) shares fell 1.9% premarket after reporting avian flu at a Florida facility, leading to the culling of 1.4M laying hens. The outbreak may impact egg prices.

Original reporting
Published Nov 18, 2026, 2:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 2:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Egg prices are on watch after Cal-Maine discloses avian flu at a Florida facility — source image
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

A highly pathogenic avian influenza detection triggers depopulation, which can reduce near-term egg supply and increase uncertainty around production schedules and costs.

02

Market read

Traders may reassess CALM’s near-term production outlook and the broader egg supply-demand balance after the new outbreak disclosure.

03

What to watch

Severity depends on containment speed, timing of depopulation, and whether the company can quickly reallocate production or source eggs from unaffected facilities.

Relevance 7/10Novelty 7/10Timing: premarket today after Cal-Maine’s Florida avian flu disclosure

Background

The article ties egg-price watch to a company-specific outbreak report from Cal-Maine’s Florida operations.

Company-level read

Ticker impact

$CALMBearishMedium confidence
Context

Cal-Maine Foods disclosed highly pathogenic avian influenza at a Florida facility, implying depopulation of about 1.4M laying hens and near-term supply disruption.

Expected impact

Likely downside bias as markets price in reduced egg output and higher operational costs tied to the Florida outbreak.

Evidence & confidence

The article reports a fresh, company-specific disease event and quantifies the affected flock size, which is directly relevant to near-term production volumes and costs.

Market effects

Heightens perceived avian influenza risk across egg producers, supporting tighter supply expectations and potentially higher wholesale egg pricing.

Florida outbreak risk can spill into regional egg availability and logistics, affecting nearby distribution channels.

Limited direct global linkage, but broader avian flu outbreaks can influence international feed and protein supply expectations.

Counterpoint

The market may already be pricing avian flu risk; if the affected flock is manageable relative to total production, the stock reaction could fade.

Key entities

  • Cal-Maine Foods

    Mississippi-based egg producer that reported avian influenza at a Florida facility and quantified depopulation of about 1.4M laying hens.

Related articles

$CALMMed

Cal-Maine to cull 1.8 million birds, halt production at Florida facility after bird flu detected

Cal-Maine Foods will cull 1.8 million birds and halt production at a Florida facility after detecting avian influenza. The cull includes 1.4 million laying hens and 360,000 pullets, representing 2.7% of its flock. The company is following USDA protocols. Bird flu has disrupted food supplies and driven up prices, though human infection risk is low, according to the CDC.

$CALMMed

Maybe There Was an Egg Cartel After All

Egg prices in the U.S. surged in 2022, initially attributed to bird flu. However, federal investigators allege that Cal-Maine, Hickman's, and Versova coordinated to artificially inflate prices through surplus bids. Prices rose 120% by December. Cal-Maine, a publicly traded company, cited the flu in its investor announcement. Antimonopoly group Farm Action questioned the price hikes, noting flock sizes didn't justify the increase.

$CALMMed

Cal-Maine Foods (CALM), Why Is It Back In Focus Today?

Cal-Maine Foods (CALM) reported a first-quarter net loss of $58.62M, down from a profit a year ago, with sales at $539.61M. The stock has declined 10.67% over 30 days and 21.94% over 90 days, but remains up 64.84% and 149.34% over three and five years. The company is expanding specialty egg and prepared foods offerings, aiming for higher margins. Analysts estimate a fair value of $68.33, with the stock currently trading at $66.67. Risks include avian influenza and oversupply pressures.

$CALMMedAI 8/10

Is Cal-Maine’s (CALM) Egg Slump Already Priced Into the Stock?

Cal-Maine Foods (CALM), the largest US egg producer, reported a weak Q1 FY2027 with net sales down 41.5% to $539.6M and a net loss of $58.6M. Specialty eggs and prepared foods, now 54.1% of sales, remained profitable. Retail demand for specialty eggs and exports rose, while supply may be tightening. Management is expanding prepared foods capacity. Conventional eggs, still dominant, saw a 59.5% sales drop due to price declines.